CLOV vs ELTX · rev $1.37B vs $132.3M cap
Clover Health Investments Corp (CLOV) versus Elicio Therapeutics Inc. (ELTX) — a side-by-side from cached financials, not a winner call.
Clover Health Investments Corp (CLOV) is a healthcare plans company listed on US.
Elicio Therapeutics Inc. (ELTX) is a biotechnology company listed on US.
Latest reported CLOV revenue for 2024-12-31 was $1.37B. Net income was -$43.0M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. CLOV currently screens at market cap $1.55B.
Latest reported ELTX revenue for 2023-03-31 was $0. Net income was -$8.0M. Revenue was down 100.0% from 2022-12-31 to 2023-03-31. ELTX currently screens at market cap $132.3M.
CLOV currently screens at market cap $1.55B. ELTX currently screens at market cap $132.3M.
Not investment advice. Open the CLOV and ELTX stock pages for the full models.
Not investment advice.